Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Quince Therapeutics Q1 EPS $(0.14) Up From $(0.51) YoY

Author: Benzinga Newsdesk | August 04, 2023 04:23am
Quince Therapeutics (NASDAQ:QNCX) reported quarterly losses of $(0.14) per share. This is a 72.55 percent increase over losses of $(0.51) per share from the same period last year.

Posted In: QNCX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist